Skip to main content
. 2017 Mar 9;44(6):950–959. doi: 10.1007/s00259-017-3665-9

Fig. 3.

Fig. 3

Average time to PSA progression following 1–3 RLT with 131I-MIP-1095. There was no association between applied radioactivity and the time to progression (first therapy: p = 0.19; second therapy: p = 0.61)